Change - Announcement of Appointment::Announcement of Appointment

Issuer & Securities

Issuer/ Manager
TIANJIN ZHONG XIN PHARM GROUP
Securities
TIANJIN ZHONG XIN PHARM GROUP - CNE100000924 - T14
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
30-Sep-2019 18:45:43
Status
New
Announcement Sub Title
Announcement of Appointment
Announcement Reference
SG190930OTHRA4DF
Submitted By (Co./ Ind. Name)
Jiao Yan
Designation
Secretary to the Board
Description (Please provide a detailed description of the event in the box below)
Announcement of Appointment of Director

Additional Details

Date Of Appointment
30/09/2019
Name Of Person
Zhang Ping
Age
50
Country Of Principal Residence
China
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
Approve of the decision
Whether appointment is executive, and if so, the area of responsibility
Duties as a Non-Executive Director of the Company
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Executive and Non-Independent Director
Professional qualifications
Senior Engineer
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
NIL
Conflict of interests (including any competing business)
NIL
Working experience and occupation(s) during the past 10 years
Mr. Zhang Ping, born in June 1969, is a Senior Engineer and holds a Bachelor Degree in Chemical Pharmaceutical Engineering from East China University of Science and Technology, a Master Degree in Business Administration from Tianjin University of Finance and Economics and a PhD in Business Administration from Nankai University. For the period from August 1991 to August 1997, he held the positions as Technical Researcher and Deputy Secretary to the Youth Committee of Tianjin Pharmaceutical Research Institute. From August 1997 to November 2006, he was successively appointed as Principal Staff Member of Organization Department, Deputy Secretary, Secretary to the Youth Committee, Director of Modernization of Traditional Chinese Medicine Department and a Supervisor of the Board of Supervisor of Tianjin Pharmaceutical Group Co., Ltd., and concurrently held office as Assistant to the General Manager of the Company for the period from March 2002 to November 2006. From November 2006 to October 2012, he was appointed as Deputy General Manager and Chief Engineer of the Company. For the period from November 2006 to November 2009, he also held position as Director of Tianjin Zhong Xin Pharmaceutical Factory, and for the period from December 2007 to December 2012, he was also a Director of the Company. From July 2010 to August 2013, he was a Member of the County Party Committee, Deputy County Chief of Qamdo County, Tibet. From June 2018 to June 2019, he served temporary position as Deputy District Mayor of Ninghe District, Tianjin. Since August 2013, he was appointed as Chief Engineer of Tianjin Pharmaceutical Group Co., Ltd. From February 2015 to present, he is holding a position of Member of the Party Committee of Tianjin Pharmaceutical Group Co., Ltd.
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
NIL
Present
NIL
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
Yes, he was an executive director of the Company from 28 December 2007 to 18 December 2012.
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
N.A.